Skip to main content
Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Pharmaceuticals: Other
Sector Health Technology
Employees 218
CEO Dr. Stephen James Farr
Address 5959 Horton Street Suite 500, Emeryville, CA 94608
Phone 1.510.550.8300
Website www.zogenix.com

Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
Zogenix, Inc. -7.45% -26.46%
Singular Genomics Systems, Inc. -4.99% n/a
Aclaris Therapeutics, Inc. 8.55% 298.01%
Rani Therapeutics Holdings, Inc. n/a n/a
Semler Scientific, Inc. 24.90% 139.19%

Statement Summary

as of 4:00 ET PM 10/26/2021
Total Assets (MRQ) 540.1 M
Total Liabilities (MRQ) 267.2 M
Shareholders’ Equity (MRQ) 272.9 M
Total Revenue (Annual) 18.8 M
Net Income (Annual) -58.9 M

Earnings And Estimates

as of 4:00 ET PM 10/26/2021

Current Qtr EPS Estimate -0.96
Current FY EPS Estimate -3.85
Long Term EPS Growth Estimate -26.76
Next Expected Earnings Date 11/5/2021

ZGNX vs S&P 500

as of 10/26/2021
Relative To
S&P 500
ZGNX
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:00 ET PM 10/26/2021
Fiscal Quarter Estimate Actual Surprise
06/2021 -0.93 -1.05 +13.01%
03/2021 -1.02 -1.00 -1.65%
12/2020 -1.00 -1.26 +25.74%
09/2020 -0.98 -1.08 +10.74%
06/2020 -1.00 -0.96 -4.21%
03/2020 -1.08 -0.54 -49.97%
12/2019 -1.04 -1.26 +20.63%
09/2019 -1.01 -6.75 +568.39%

Financial Strength

as of 4:00 ET PM 10/26/2021
Pre-Tax Margin -313.46
Net Margin 93.93
Operating Margin -292.36
Return On Equity -72.21
Return On Assets -44.70
Inventory Turnover (TTM) 7.31
Sales Growth (MRQ) -13.20

Ratios

as of 4:00 PM ET 10/26/2021
Price/Earnings (TTM) n/a
Price/Book (MRQ) 3.23
Price/Cash Flow (TTM) 0.00
Book Value (MRQ) 4.88
Quick Ratio (MRQ) 5.96
Current Ratio (MRQ) 6.01
Total Debt/Equity (MRQ) 0.60

Short Interest

as of 4:00 PM ET 10/27/2021
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date n/a n/a
Short Interest Shares 0 0
Short Interest Ratio 0.0 0.0
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:00 ET PM 10/26/2021
Current Qtr
(09/2021)
Next Qtr
(12/2021)
Consensus Estimate $-0.96 $-0.84
# of Estimates 12 12
High Estimate $-0.81 $-0.55
Low Estimate $-1.05 $-1.07
Year Ago EPS $-1.08 $-1.26
Year Over Year Growth Estimate -11.40% -33.55%
Current Yr
(12/2021)
Next Yr
(12/2022)
Consensus Estimate $-3.85 $-2.28
# of Estimates 12 12
High Estimate $-3.50 $-0.19
Low Estimate $-4.18 $-4.45
Year Ago EPS $-3.90 $-3.85
Year Over Year Growth Estimate -1.34% -40.64%
Current Qtr
(09/2021)
Next Qtr
(12/2021)
Current Year
(12/2021)
Next Year
(12/2022)
Consensus Estimate $-0.96 $-0.84 $-3.85 $-2.28
# of Estimates 12 12 12 12
High Estimate $-0.81 $-0.55 $-3.50 $-0.19
Low Estimate $-1.05 $-1.07 $-4.18 $-4.45
Year Ago EPS $-1.08 $-1.26 $-3.90 $-3.85
Year Over Year Growth Estimate -11.40% -33.55% -1.34% -40.64%

Insider Information Summary

as of 09/30/2021
% Insiders - 1.48%
% Remaining Total Shares - 98.52%
Current 1 Month
Net Insider Transaction 12.39 K 12.39 K
Shares Bought 13.50 K 13.50 K
Shares Sold 1.11 K 1.11 K

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Edge data centres are smaller facilities, compared with the hyperscale operations run by the likes of Amazon Web Services and Google. These facilities provide cloud computing resources and cached streaming content closer to local end users. Photo: Xinhua

Cramer's Mad Money Recap 10/27: Google, Microsoft, Apple, Tesla

Jim Cramer says big tech companies in the U.S. are the best in the world, and could be even greater with clear regulation for digital commerce.

Twilio Lead

Wolfspeed, Twilio Active After Earnings

Sharp moves seen in after-hours trading for company formerly known as Cree and software and services provider Twilio.

Hong Kong Stocks Surrender Gains As Covid-19 Cases Trigger Curbs In China While Mainland Funds Retreat

Paul Price Sees Value In This Overlooked Retail Stock

Investors may be missing out on PriceSmart because it doesn't operate in the U.S.